MAM
McCarthy Asset Management Portfolio holdings
AUM
$147M
This Quarter Return
+5.5%
1 Year Return
+8.48%
3 Year Return
+38.27%
5 Year Return
–
10 Year Return
–
AUM
$141M
AUM Growth
+$141M
(+10%)
Cap. Flow
+$5.7M
Cap. Flow
% of AUM
4.05%
Top 10 Holdings %
Top 10 Hldgs %
77.1%
Holding
470
New
78
Increased
61
Reduced
71
Closed
34
Top Buys
Top Sells
| 1 |
Abbott
ABT
|
$1.29M |
| 2 |
Schwab US Broad Market ETF
SCHB
|
$900K |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
$886K |
| 4 |
Gilead Sciences
GILD
|
$656K |
| 5 |
Vanguard Dividend Appreciation ETF
VIG
|
$626K |
Sector Composition
| 1 | Healthcare | 8.93% |
| 2 | Technology | 6.87% |
| 3 | Financials | 3.42% |
| 4 | Consumer Discretionary | 2.95% |
| 5 | Communication Services | 2.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Chemed
CHE
$6.67B
| $130K | 0.09% |
274
| – | – |
|
52
Mettler-Toledo International
MTD
$26.8B
| $121K | 0.09% |
+87
| New | +$121K |
|
53
Vanguard Mid-Cap ETF
VO
$87.5B
| $120K | 0.09% |
505
-1
| -0.2% | -$238 |
|
54
Acadia Pharmaceuticals
ACAD
$4.38B
| $111K | 0.08% |
4,531
+2,331
| +106% | +$57.1K |
|
55
NVIDIA
NVDA
$4.24T
| $111K | 0.08% |
139
| – | – |
|
56
JPMorgan Chase
JPM
$829B
| $110K | 0.08% |
708
+198
| +39% | +$30.8K |
|
57
Schwab US Large-Cap Value ETF
SCHV
$13.2B
| $108K | 0.08% |
1,584
+6
| +0.4% | +$409 |
|
58
Home Depot
HD
$405B
| $107K | 0.08% |
337
+82
| +32% | +$26K |
|
59
Idexx Laboratories
IDXX
$51.8B
| $107K | 0.08% |
170
| – | – |
|
|
ZIXI
60
DELISTED
Zix Corporation
ZIXI
| $106K | 0.08% |
15,000
| – | – |
|
61
UGI
UGI
$7.44B
| $104K | 0.07% |
2,250
| – | – |
|
62
Northrop Grumman
NOC
$84.5B
| $103K | 0.07% |
284
+1
| +0.4% | +$363 |
|
63
Broadcom
AVGO
$1.4T
| $101K | 0.07% |
212
+24
| +13% | +$11.4K |
|
64
GE Aerospace
GE
$292B
| $96K | 0.07% |
7,146
-597
| -8% | -$8.02K |
|
65
Ball Corp
BALL
$14.3B
| $95K | 0.07% |
1,172
| – | – |
|
66
iShares Silver Trust
SLV
$19.6B
| $88K | 0.06% |
3,613
| – | – |
|
67
Schwab Fundamental US Large Company Index ETF
FNDX
$19.8B
| $82K | 0.06% |
1,493
+7
| +0.5% | +$384 |
|
68
Pfizer
PFE
$141B
| $82K | 0.06% |
2,084
+3
| +0.1% | +$118 |
|
69
SPDR S&P Biotech ETF
XBI
$5.07B
| $81K | 0.06% |
597
| – | – |
|
70
CVS Health
CVS
$92.8B
| $80K | 0.06% |
963
+134
| +16% | +$11.1K |
|
71
Okta
OKTA
$16.4B
| $73K | 0.05% |
300
| – | – |
|
72
AbbVie
ABBV
$372B
| $72K | 0.05% |
641
-1,860
| -74% | -$209K |
|
73
General Motors
GM
$55.8B
| $72K | 0.05% |
1,211
-17
| -1% | -$1.01K |
|
74
Regeneron Pharmaceuticals
REGN
$61.5B
| $71K | 0.05% |
128
| – | – |
|
|
SWI
75
DELISTED
SolarWinds Corporation Common Stock
SWI
| $68K | 0.05% |
4,000
-2,880
| -42% | -$49K |
|